Condensed Consolidated Statements of Cash Flows (USD $)	9 Months Ended
	Sep. 30, 2012		Sep. 30, 2011
Cash flows from operating activities:
Net loss	$ (1,546,000)		$ (4,022,000)
Adjustments to reconcile net loss to cash used in operating activities:
Bad debt expense	484,000		165,000
Proceeds from sale of New Jersey net operating loss carryforwards	390,000		0
Stock-based compensation expense	865,000		911,000
Depreciation and amortization	1,644,000		1,796,000
Issuance of warrants			137,000
Other non-cash items	19,000		73,000
Changes in:
Accounts receivable	147,000		498,000
Note and lease receivable	(8,060,000)		(2,254,000)
Inventory	(590,000)		(1,125,000)
Prepaid expenses and other assets	611,000		66,000
Deferred costs	(1,361,000)		393,000
Deferred revenue	2,691,000		488,000
Accounts payable and accrued expenses	(1,359,000)		(917,000)
Net cash used in operating activities	(6,065,000)		(3,791,000)
Cash flows from investing activities:
Expenditures for fixed assets including website development costs	(238,000)		(211,000)
Purchase of investments	(4,252,000)		(2,889,000)
Maturities of investments	7,087,000		1,618,000
Net cash (used in) provided by investing activities	2,597,000		(1,482,000)
Cash flows from financing activities:
Proceeds from issuance of shares to Avis	0		4,605,000
Proceeds from exercise of stock options	101,000		35,000
Purchase of treasury shares	(193,000)		(1,050,000)
Net cash provided by (used in) financing activities	(92,000)		3,590,000
Effect of foreign exchange rate changes on cash and cash equivalents	(195,000)		(5,000)
Net decrease in cash and cash equivalents	(3,755,000)		(1,688,000)
Cash and cash equivalents - beginning of period	8,386,000	[1]	14,491,000
Cash and cash equivalents - end of period	4,631,000		12,803,000
Supplemental disclosure of cash flow information:
Taxes	0		0
Interest	0		0
Noncash activities:
Unrealized gain on investments	111,000		17,000
Shares withheld pursuant to stock issuance	$ 247,000		$ 47,000

[1] Derived from audited balance sheet as of December 31, 2011